Unpredictable thriller, fast-paced with twists and turns the whole way through. What a debut novel.

Raised a few discussions regarding the implants, are they in the pipeline?

Fantastic book. Would make a good film.

A new author for me to watch out for.

Thank you MetGalley for letting me read this book prior to release.

A decent debut book, that has a lot going on.
There were no big surprises for me, but I enjoyed the writing style, and there were times when the pace picked up very nicely.
Sarah is a good solid main character and she had my sympathy for the majority of the book... not that she needed it.
An entertaining read.

Geneva is a thriller that picks up on many of the current topics in the world around us. Corruption and greed, the role of the internet with its bloggers and podcasters (and sometimes, its conspiracy theorists), the power of corporations in general and Big Pharma in particular, the sense of panic over the proliferation of health issues like Alzheimer's disease, the march of science and the debates around it, and so on.

Sarah is a Nobel Prize-winning scientist who has retired from work in order to spend more time with her daughter Maddie, her husband Daniel, and her father who has Alzheimer's disease. A major factor behind her decision is the realisation that Sarah herself has begun to experience early symptoms of the disease.

But in a new development, a pharmaceuticals company based Switzerland has announced the development of a new drug to treat this disease. Despite being invited to be a keynote speaker at the launch of this product, Sarah is reluctant to accept - also because she fears that her symptoms will become visible to others.

But her husband Daniel, also a scientist, is insistent that this will be a good step for Sarah to take. Needless to say, this causes some tension between the two.

Upon arrival in Geneva it becomes clear that something altogether more sinister is unfolding here. Sarah finds herself at the centre of a combination of corporate greed, convincing lies, half baked science and a wider conspiracy which is not easy to unravel.

Amidst the stunning natural beauty of Geneva, it seems something far uglier is lurking beneath the surface...

Geneva is a thriller that picks up on many of the current topics in the world around us. Corruption and greed, the role of the internet with its bloggers and podcasters (and sometimes, its conspiracy theorists), the power of corporations in general and Big Pharma in particular, the sense of panic over the proliferation of health issues like Alzheimer's disease, the march of science and the debates around it, and so on.

Sarah is a Nobel Prize-winning scientist who has retired from work in order to spend more time with her daughter Maddie, her husband Daniel, and her father who has Alzheimer's disease. A major factor behind her decision is the realisation that Sarah herself has begun to experience early symptoms of the disease.

But in a new development, a pharmaceuticals company based Switzerland has announced the development of a new drug to treat this disease. Despite being invited to be a keynote speaker at the launch of this product, Sarah is reluctant to accept - also because she fears that her symptoms will become visible to others.

But her husband Daniel, also a scientist, is insistent that this will be a good step for Sarah to take. Needless to say, this causes some tension between the two.

Upon arrival in Geneva it becomes clear that something altogether more sinister is unfolding here. Sarah finds herself at the centre of a combination of corporate greed, convincing lies, half baked science and a wider conspiracy which is not easy to unravel.

Amidst the stunning natural beauty of Geneva, it seems something far uglier is lurking beneath the surface...

It's an enjoyable read, and this book gets 3.5 stars from me. It would have got 4 if not for the somewhat convenient and not entirely convincing ending.